Neurofilament Light Chain Levels in a Large Idiopathic Peripheral Neuropathy Cohort
Journal of the Peripheral Nervous System · 2025
DOI: 10.1111/jns.70050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Simone Thomas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Neurofilament Proteins, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Neurofilament light chain (Nf‐L) has been identified as a biomarker of neurodegeneration in many neuromuscular conditions, including several subtypes of polyneuropathies. The purpose of this research was to investigate whether Nf‐L is also a promising biomarker for idiopathic peripheral neuropathy (IPN), the second most common subtype of axonal polyneuropathy.
Methods
Nf‐L levels were quantified using an ultrasensitive digital immunoassay SiMoA in plasma samples from 294 subjects. Participant inclusion required a diagnosis of IPN confirmed by electrodiagnostic testing, intraepidermal nerve fiber density (IENFD), and/or neuromuscular examination. Laboratory testing recommended by the American Academy of Neurology for the evaluation of polyneuropathy was normal in all subjects.
Results
In our cohort, the majority of participants (78.1%, N = 228) had Nf‐L levels in the age‐adjusted normal range. Those with elevated Nf‐L levels had higher scores on two different neuropathy severity scores and were more likely to have abnormal electrodiagnostic testing, including reduced action potential amplitude in peroneal motor and sural sensory nerves. No differences in blood Nf‐L levels were observed in those participants with a short duration (≤ 1.5 years) versus long duration (≥ 5 years) of disease. Nf‐L levels were also not correlated with the presence of neuropathic pain, nor the location of paresthesia. Nf‐L expression had the strongest correlation with age.
Conclusions
In this cohort with IPN, Nf‐L levels correlated with disease severity as assessed by clinical examination and electrophysiology. However, given that Nf‐L was in the normal range for the majority of subjects in our cohort, its use as a biomarker for clinical trials evaluating new treatments for IPN will be limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Merkin Peripheral Neuropathy and Nerve Regeneration Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Simone Thomas
Zitieren
APA
Thomas, S., Khan, M., Sari, M. C., Hu, X., Lewis, A., Lobana, J., Mukherjee-Clavin, B., Moghekar, A., Morrison, B. M., Sumner, C., Xie, S., & Höke, A. (2025). Neurofilament Light Chain Levels in a Large Idiopathic Peripheral Neuropathy Cohort. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70050
Vancouver
Thomas S, Khan M, Sari MC, Hu X, Lewis A, Lobana J, et al. Neurofilament Light Chain Levels in a Large Idiopathic Peripheral Neuropathy Cohort. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70050
BibTeX
@article{Thomas2025,
author = {Thomas, Simone and Khan, Maaz and Sari, Mehmet Can and Hu, Xindan and Lewis, Alexandria and Lobana, Jashandeep and Mukherjee-Clavin, Bipasha and Moghekar, Abhay and Morrison, Brett M and Sumner, Charlotte and Xie, Samuel and Höke, Ahmet},
title = {Neurofilament Light Chain Levels in a Large Idiopathic Peripheral Neuropathy Cohort},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
doi = {10.1111/jns.70050}
}
EUVIMED